US 9074212
RNAi inhibition of alpha-ENaC expression
granted A61KA61K31/713A61K45/06
Quick answer
US patent 9074212 (RNAi inhibition of alpha-ENaC expression) held by Arrowhead Research Corporation expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Research Corporation
- Grant date
- Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/713, A61K45/06, A61P, A61P11/00